Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study.
Piccaluga PP, Malagola M, Rondoni M, Arpinati M, Paolini S, Candoni A, Fanin R, Messa E, Pirrotta MT, Lauria F, Visani G, Alberti D, Rancati F, Vinaccia V, Russo D, Saglio G, Baccarani M, Martinelli G.
Piccaluga PP, et al. Among authors: fanin r.
Haematologica. 2007 Dec;92(12):1721-2. doi: 10.3324/haematol.11345.
Haematologica. 2007.
PMID: 18056005
Free article.
Clinical Trial.